Medication info
Teneldim Extended-Release Tablet 10/500 mg

Teneldim Extended-Release Tablet 10/500 mg

Prescription medicationTablet경구
Ingredient · strength
Teneligliptin Hydrochloride Hydrate›13mg / 1 tabletMetformin Hydrochloride›500mg / 1 tablet
Manufacturer / importer
국제약품(주)
Appearance
Orange egg-shaped extended-release film-coated tablet
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 202201411 · Approved 2022.04.04 · Insurance code 643705300

Summary

Main use
Improvement of blood glucose control in type 2 diabetes
Who takes it
Adults
Adult dose
The usual dosage of this medication is administered once daily with the evening meal. For 20/1000 mg extended-release tablets, take one tablet daily. For 10/750 mg or 10/500 mg extended-release tablets, take two tablets each time, once daily. The initial dosage consists of teneligliptin 20 mg once daily and the regular dose of metformin. The maximum recommended dose is teneligliptin 20 mg and extended-release metformin.

Ingredients

Manufacturer
국제약품(주)

Efficacy & effects

Improvement of blood glucose control in type 2 diabetes

View approved original text

This medication is used to assist patients with type 2 diabetes in controlling their blood glucose levels. When administered in conjunction with dietary and exercise therapy, it helps manage blood glucose levels effectively. The two active ingredients, teneligliptin and metformin, work together to enhance blood glucose control. This can lead to positive outcomes in diabetes management.

How to take

Adult dose

The usual dosage of this medication is administered once daily with the evening meal. For 20/1000 mg extended-release tablets, take one tablet daily. For 10/750 mg or 10/500 mg extended-release tablets, take two tablets each time, once daily. The initial dosage consists of teneligliptin 20 mg once daily and the regular dose of metformin. The maximum recommended dose is teneligliptin 20 mg and extended-release metformin.

Precautions

This medication is used to control blood glucose and should not be administered to patients with impaired kidney function or severe heart failure. Additionally, it should be temporarily discontinued in cases of acute renal failure, severe infections, or before and after surgery, and can be resumed only after kidney function has returned to normal. It can lead to a rare but serious side effect called lactic acidosis, which is more likely to occur in circumstances of diminished kidney function, liver dysfunction, severe dehydration, or cardiopulmonary disease. Symptoms of lactic acidosis may include fatigue, muscle pain, dyspnea, and abdominal pain, and should prompt immediate consultation with a physician. When combined with other diabetes medications, this drug may increase the risk of hypoglycemia, so patients should be aware of symptoms and management strategies for hypoglycemia. Moreover, excessive alcohol consumption can elevate the risk of lactic acidosis, so it is advisable to avoid drinking alcohol. Patients should have regular kidney function and blood tests while taking this medication, and it is particularly important to monitor vitamin B12 levels. It is safe for pregnant women or those who may become pregnant, as well as breastfeeding women, to refrain from using this medication. If symptoms such as dizziness, abdominal pain, skin rash, or dyspnea occur, medical attention should be sought immediately. Elderly patients may have reduced kidney function; therefore, dosage adjustments and regular monitoring may be necessary. During the course of this medication, any sudden vomiting, diarrhea, or dehydration symptoms should prompt a consultation with a physician to adjust the medication as necessary. Care should be taken during driving or performing tasks requiring concentration due to the risk of hypoglycemia or dizziness.

Side effects and when to seek care immediately

Serious side effects

Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with fever, blisters, peeling skin, pain in mucous membranes of mouth/eyes, shortness of breath or difficulty breathing, asthma attack, respiratory changes with cough and fever, yellowing of skin or eyes (jaundice), profound malaise, sudden and severe headaches, thunderclap headache, seizures, altered consciousness, visual disturbances, paralysis, urination changes

Mild side effects

  • Hypoglycemia
  • constipation
  • dizziness
  • abdominal distension
  • abdominal discomfort
  • nausea
  • abdominal pain
  • bloating
  • stomatitis
  • gastric polyp
Show 20 more
  • colon polyp
  • duodenal ulcer
  • gastroesophageal reflux disease
  • diarrhea
  • decreased appetite
  • increased amylase
  • increased lipase
  • elevated AST (GOT)
  • elevated ALT (GPT)
  • elevated GGT
  • elevated ALP
  • proteinuria
  • ketonuria
  • potential hematuria
  • eczema
  • rash
  • itching
  • allergic dermatitis
  • arthralgia
  • CK (CPK)

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent air exposure, and the temperature should be maintained between 1 and 30 degrees Celsius at room temperature. Proper storage helps maintain the effectiveness of the medication.

Appearance and packaging

Appearance

Orange egg-shaped extended-release film-coated tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.